Cargando…
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254651/ https://www.ncbi.nlm.nih.gov/pubmed/35803386 http://dx.doi.org/10.1016/j.jinf.2022.06.033 |
_version_ | 1784740748032212992 |
---|---|
author | Martin-Blondel, Guillaume Marcelin, Anne-Genevieve Soulié, Cathia Kaisaridi, Sofia Lusivika-Nzinga, Clovis Dorival, Céline Nailler, Laura Boston, Anaïs Melenotte, Cléa Cabié, André Choquet, Christophe Coustillères, François Martellosio, Jean-Philippe Gaube, Géraldine Trinh-Duc, Albert Ronchetti, Anne-Marie Pourcher, Valerie Chauveau, Marie Lacombe, Karine Peiffer-Smadja, Nathan Housset, Pierre Perrot, Aurore Pialoux, Gilles Martin, Aurélie Dubee, Vincent Devaux, Mathilde Frey, Jérôme Cazanave, Charles Liblau, Roland Carrat, Fabrice Yordanov, Youri |
author_facet | Martin-Blondel, Guillaume Marcelin, Anne-Genevieve Soulié, Cathia Kaisaridi, Sofia Lusivika-Nzinga, Clovis Dorival, Céline Nailler, Laura Boston, Anaïs Melenotte, Cléa Cabié, André Choquet, Christophe Coustillères, François Martellosio, Jean-Philippe Gaube, Géraldine Trinh-Duc, Albert Ronchetti, Anne-Marie Pourcher, Valerie Chauveau, Marie Lacombe, Karine Peiffer-Smadja, Nathan Housset, Pierre Perrot, Aurore Pialoux, Gilles Martin, Aurélie Dubee, Vincent Devaux, Mathilde Frey, Jérôme Cazanave, Charles Liblau, Roland Carrat, Fabrice Yordanov, Youri |
author_sort | Martin-Blondel, Guillaume |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9254651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92546512022-07-05 Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 Martin-Blondel, Guillaume Marcelin, Anne-Genevieve Soulié, Cathia Kaisaridi, Sofia Lusivika-Nzinga, Clovis Dorival, Céline Nailler, Laura Boston, Anaïs Melenotte, Cléa Cabié, André Choquet, Christophe Coustillères, François Martellosio, Jean-Philippe Gaube, Géraldine Trinh-Duc, Albert Ronchetti, Anne-Marie Pourcher, Valerie Chauveau, Marie Lacombe, Karine Peiffer-Smadja, Nathan Housset, Pierre Perrot, Aurore Pialoux, Gilles Martin, Aurélie Dubee, Vincent Devaux, Mathilde Frey, Jérôme Cazanave, Charles Liblau, Roland Carrat, Fabrice Yordanov, Youri J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-10 2022-07-05 /pmc/articles/PMC9254651/ /pubmed/35803386 http://dx.doi.org/10.1016/j.jinf.2022.06.033 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Martin-Blondel, Guillaume Marcelin, Anne-Genevieve Soulié, Cathia Kaisaridi, Sofia Lusivika-Nzinga, Clovis Dorival, Céline Nailler, Laura Boston, Anaïs Melenotte, Cléa Cabié, André Choquet, Christophe Coustillères, François Martellosio, Jean-Philippe Gaube, Géraldine Trinh-Duc, Albert Ronchetti, Anne-Marie Pourcher, Valerie Chauveau, Marie Lacombe, Karine Peiffer-Smadja, Nathan Housset, Pierre Perrot, Aurore Pialoux, Gilles Martin, Aurélie Dubee, Vincent Devaux, Mathilde Frey, Jérôme Cazanave, Charles Liblau, Roland Carrat, Fabrice Yordanov, Youri Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 |
title | Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 |
title_full | Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 |
title_fullStr | Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 |
title_full_unstemmed | Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 |
title_short | Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2 |
title_sort | sotrovimab to prevent severe covid-19 in high-risk patients infected with omicron ba.2 |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254651/ https://www.ncbi.nlm.nih.gov/pubmed/35803386 http://dx.doi.org/10.1016/j.jinf.2022.06.033 |
work_keys_str_mv | AT martinblondelguillaume sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT marcelinannegenevieve sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT souliecathia sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT kaisaridisofia sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT lusivikanzingaclovis sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT dorivalceline sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT naillerlaura sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT bostonanais sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT melenotteclea sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT cabieandre sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT choquetchristophe sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT coustilleresfrancois sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT martellosiojeanphilippe sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT gaubegeraldine sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT trinhducalbert sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT ronchettiannemarie sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT pourchervalerie sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT chauveaumarie sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT lacombekarine sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT peiffersmadjanathan sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT houssetpierre sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT perrotaurore sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT pialouxgilles sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT martinaurelie sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT dubeevincent sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT devauxmathilde sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT freyjerome sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT cazanavecharles sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT liblauroland sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT carratfabrice sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 AT yordanovyouri sotrovimabtopreventseverecovid19inhighriskpatientsinfectedwithomicronba2 |